Key terms
About MEDP
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MEDP news
Mar 18
6:46am ET
Medpace initiated with a Hold at Deutsche Bank
Mar 08
9:21am ET
Medpace price target raised to $480 from $452 at UBS
Feb 15
5:12am ET
Medpace upgraded to Buy from Neutral at UBS
Feb 15
1:02am ET
A New Cause for Concern: Medpace Holdings Inc Adds a New Technology Risk
Feb 14
6:30am ET
Medpace price target raised to $408 from $312 at Baird
Feb 12
4:19pm ET
Medpace sees FY24 EPS $10.18-$10.87, consensus $9.96
Feb 12
4:18pm ET
Medpace reports Q4 EPS $2.46, consensus $2.22
Jan 17
6:33am ET
Medpace price target raised to $312 from $302 at Baird
No recent press releases are available for MEDP
MEDP Financials
Key terms
Ad Feedback
MEDP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MEDP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
